NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 6 - Endocrine system 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

06.06.01 Calcitonin and parathyroid hormone

Abaloparatide (Eladynos®)
(80 microgram solution for injection in pre-filled pen)

RED
Restricted Drug Restricted

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

 
Restricted - secondary care prescribing in line with the below NICA TA(s):

Calcitonin (salmon) / Salcatonin

RED
Restricted Drug Restricted

50Unit/1mL , 100Unit/1mL 

N.B. 400unit strength has been discontinued.

Teriparatide (Sondelbay®)

RED
Restricted Drug Restricted

FOR ALL PRESCRIBING – Blueteq or High cost drug form required – see link from Formulary homepage.

Existing patients will continue using Terrosa until their 2 year treatment finishes. Any new patients as of March 2024 are being prescribed Sondelbay.


Restricted - secondary care prescribing in-line with the below NICA TA(s):

 

Entry reviewed: Oct 2024

Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.